To mount an effective government response to anthrax outbreaks in Indonesia's Yogyakarta Special Region, policymakers must ...

Acurx Pharmaceuticals, Inc. ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today ...

StockNews.com cut shares of Emergent BioSolutions (NYSE:EBS – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday. Several other analysts have also ...

Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Emergent BioSolutions in a report released on Tuesday, March 4th. HC Wainwright analyst R. Selvaraju ...